MOH vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

MOH

28.0
AI Score
VS
CLOV Wins

CLOV

42.5
AI Score

Investment Advisor Scores

MOH

28score
Recommendation
SELL

CLOV

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MOH CLOV Winner
Revenue 32.75B 1.49B MOH
Net Income 112.00M 55.34M MOH
Net Margin 0.3% 3.7% CLOV
Operating Income 334.00M 55.34M MOH
ROE 2.7% 14.7% CLOV
ROA 0.7% 7.7% CLOV
Total Assets 15.65B 720.33M MOH
Current Ratio 1.69 1.50 MOH
Free Cash Flow 535.00M 131.55M MOH

Relative Price Performance (Last 90 Days)

MOH 1M: +8.2% · 3M: +4.8% CLOV 1M: +2.0% · 3M: +7.7%

Current Technical Phase

MOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.5 · Price: $209.15

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 50

RSI (14): 50.2 · Price: $4.60

Fundamentals Snapshot

Metric MOH CLOV
Market Cap — —
Forward P/E 24.5 30.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.6%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS -0.74 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.